REFERENCE
Kato J, Mori T, Yokoyama K, Tsukada Y, Ueda T, Shimizu T, Okamoto S.Safety and efficacy of high-dose ranimustine, cytarabine, etoposide and CY (MCVAC) regimen followed by autologous peripheral blood stem cell transplantation for high-risk diffuse large B-cell lymphoma. Bone Marrow Transplantation 46: 923-928, No. 7, Jul 2011. Available from: URL: http://dx.doi.org/10.1038/bmt.2010.243 - Japan
Rights and permissions
About this article
Cite this article
Antineoplastics. React. Wkly. 1368, 7 (2011). https://doi.org/10.2165/00128415-201113680-00022
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128415-201113680-00022